Correlation Between Medigen Vaccine and Genovate Biotechnology
Can any of the company-specific risk be diversified away by investing in both Medigen Vaccine and Genovate Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Vaccine and Genovate Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medigen Vaccine Biologics and Genovate Biotechnology Co, you can compare the effects of market volatilities on Medigen Vaccine and Genovate Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Vaccine with a short position of Genovate Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Vaccine and Genovate Biotechnology.
Diversification Opportunities for Medigen Vaccine and Genovate Biotechnology
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Medigen and Genovate is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Vaccine Biologics and Genovate Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genovate Biotechnology and Medigen Vaccine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Vaccine Biologics are associated (or correlated) with Genovate Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genovate Biotechnology has no effect on the direction of Medigen Vaccine i.e., Medigen Vaccine and Genovate Biotechnology go up and down completely randomly.
Pair Corralation between Medigen Vaccine and Genovate Biotechnology
Assuming the 90 days trading horizon Medigen Vaccine Biologics is expected to under-perform the Genovate Biotechnology. In addition to that, Medigen Vaccine is 3.75 times more volatile than Genovate Biotechnology Co. It trades about -0.01 of its total potential returns per unit of risk. Genovate Biotechnology Co is currently generating about 0.27 per unit of volatility. If you would invest 2,320 in Genovate Biotechnology Co on November 28, 2024 and sell it today you would earn a total of 90.00 from holding Genovate Biotechnology Co or generate 3.88% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Medigen Vaccine Biologics vs. Genovate Biotechnology Co
Performance |
| Timeline |
| Medigen Vaccine Biologics |
| Genovate Biotechnology |
Medigen Vaccine and Genovate Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Medigen Vaccine and Genovate Biotechnology
The main advantage of trading using opposite Medigen Vaccine and Genovate Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Vaccine position performs unexpectedly, Genovate Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genovate Biotechnology will offset losses from the drop in Genovate Biotechnology's long position.| Medigen Vaccine vs. Evergreen Marine Corp | Medigen Vaccine vs. Yang Ming Marine | Medigen Vaccine vs. Eva Airways Corp | Medigen Vaccine vs. Wan Hai Lines |
| Genovate Biotechnology vs. Johnson Health Tech | Genovate Biotechnology vs. Hunya Foods Co | Genovate Biotechnology vs. Sporton International | Genovate Biotechnology vs. Mechema Chemicals Int |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |